Cases & Deals

Orthovita undertakes its initial public offering

Clients Orthovita

Jones Day advised Orthovita, a U.S.-based biotech company on its IPO on the EASDAQ, the first time a U.S. company undertook its initial public offering of securities on this European-wide stock exchange.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.